BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1179 related articles for article (PubMed ID: 27477896)

  • 1. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S;
    Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Diez MC; Tagarro I; Leselbaum A; Danese S;
    Gastroenterology; 2018 Apr; 154(5):1334-1342.e4. PubMed ID: 29277560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.
    Furukawa S; Mizushima T; Nakaya R; Shibata M; Yamaguchi T; Watanabe K; Futami K
    J Crohns Colitis; 2023 Apr; 17(3):369-378. PubMed ID: 36149832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease.
    Scott LJ
    BioDrugs; 2018 Dec; 32(6):627-634. PubMed ID: 30298387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.
    Dawoud C; Widmann KM; Czipin S; Pramhas M; Scharitzer M; Stift A; Harpain F; Riss S
    Wien Klin Wochenschr; 2024 May; 136(9-10):289-294. PubMed ID: 37823920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.
    de la Portilla F; Alba F; García-Olmo D; Herrerías JM; González FX; Galindo A
    Int J Colorectal Dis; 2013 Mar; 28(3):313-23. PubMed ID: 23053677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
    Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
    Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE
    J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
    Meng ZW; Baumgart DC
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Laureti S; Gionchetti P; Cappelli A; Vittori L; Contedini F; Rizzello F; Golfieri R; Campieri M; Poggioli G
    Inflamm Bowel Dis; 2020 Jan; 26(2):321-330. PubMed ID: 31220252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial.
    Park KJ; Ryoo SB; Kim JS; Kim TI; Baik SH; Kim HJ; Lee KY; Kim M; Kim WH
    Colorectal Dis; 2016 May; 18(5):468-76. PubMed ID: 26603576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
    Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
    Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease.
    Castro-Poceiro J; Fernández-Clotet A; Panés J
    Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn's disease.
    Philandrianos C; Serrero M; Grimaud F; Magalon J; Visée C; Velier M; Francois P; Orsoni P; Magalon G; Grimaud JC; Desjeux A; Véran J; Sabatier F
    Stem Cell Res Ther; 2018 Jan; 9(1):4. PubMed ID: 29321063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.
    Garcia-Olmo D; Herreros D; Pascual I; Pascual JA; Del-Valle E; Zorrilla J; De-La-Quintana P; Garcia-Arranz M; Pascual M
    Dis Colon Rectum; 2009 Jan; 52(1):79-86. PubMed ID: 19273960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
    Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.
    Kotze PG; Spinelli A; Warusavitarne J; Di Candido F; Sahnan K; Adegbola SO; Danese S
    Drugs Today (Barc); 2019 Feb; 55(2):95-105. PubMed ID: 30816884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.